Alfred D Kingsley - Net Worth and Insider Trading

Alfred D Kingsley Net Worth

The estimated net worth of Alfred D Kingsley is at least $6 Million dollars as of 2024-11-06. Alfred D Kingsley is the See Remarks of Lineage Cell Therapeutics Inc and owns about 7,300,252 shares of Lineage Cell Therapeutics Inc (LCTX) stock worth over $6 Million. Alfred D Kingsley is the Director of OncoCyte Corp and owns about 28,161 shares of OncoCyte Corp (OCX) stock worth over $82,230. Alfred D Kingsley is also the Director of Asterias Biotherapeutics Inc and owns about 9,000 shares of Asterias Biotherapeutics Inc (AST) stock worth over $8,505. Details can be seen in Alfred D Kingsley's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alfred D Kingsley has not made any transactions after 2023-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Alfred D Kingsley

To

Alfred D Kingsley Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Alfred D Kingsley owns 3 companies in total, including Lineage Cell Therapeutics Inc (LCTX) , OncoCyte Corp (OCX) , and Asterias Biotherapeutics Inc (AST) .

Click here to see the complete history of Alfred D Kingsley’s form 4 insider trades.

Insider Ownership Summary of Alfred D Kingsley

Ticker Comapny Transaction Date Type of Owner
LCTX Lineage Cell Therapeutics Inc 2017-07-31 other: 13D Group-10% Owner
OCX OncoCyte Corp 2023-06-14 director
AST Asterias Biotherapeutics Inc 2016-06-09 director

Alfred D Kingsley Latest Holdings Summary

Alfred D Kingsley currently owns a total of 3 stocks. Among these stocks, Alfred D Kingsley owns 7,300,252 shares of Lineage Cell Therapeutics Inc (LCTX) as of July 31, 2017, with a value of $6 Million and a weighting of 98.55%. Alfred D Kingsley owns 28,161 shares of OncoCyte Corp (OCX) as of June 14, 2023, with a value of $82,230 and a weighting of 1.31%. Alfred D Kingsley also owns 9,000 shares of Asterias Biotherapeutics Inc (AST) as of June 9, 2016, with a value of $8,505 and a weighting of 0.14%.

Latest Holdings of Alfred D Kingsley

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
LCTX Lineage Cell Therapeutics Inc 2017-07-31 7,300,252 0.84 6,165,063
OCX OncoCyte Corp 2023-06-14 28,161 2.92 82,230
AST Asterias Biotherapeutics Inc 2016-06-09 9,000 0.95 8,505

Holding Weightings of Alfred D Kingsley


Alfred D Kingsley Form 4 Trading Tracker

According to the SEC Form 4 filings, Alfred D Kingsley has made a total of 0 transactions in Lineage Cell Therapeutics Inc (LCTX) over the past 5 years. The most-recent trade in Lineage Cell Therapeutics Inc is the sale of 150,000 shares on July 31, 2017, which brought Alfred D Kingsley around $420,000.

According to the SEC Form 4 filings, Alfred D Kingsley has made a total of 5 transactions in OncoCyte Corp (OCX) over the past 5 years, including 3 buys and 2 sells. The most-recent trade in OncoCyte Corp is the acquisition of 1,500 shares on June 14, 2023, which cost Alfred D Kingsley around $6,300.

According to the SEC Form 4 filings, Alfred D Kingsley has made a total of 0 transactions in Asterias Biotherapeutics Inc (AST) over the past 5 years. The most-recent trade in Asterias Biotherapeutics Inc is the acquisition of 4,000 shares on June 9, 2016, which cost Alfred D Kingsley around $11,720.

Insider Trading History of Alfred D Kingsley

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Alfred D Kingsley Trading Performance

GuruFocus tracks the stock performance after each of Alfred D Kingsley's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alfred D Kingsley is -12.21%. GuruFocus also compares Alfred D Kingsley's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alfred D Kingsley within 3 months outperforms 2 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Alfred D Kingsley's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Alfred D Kingsley

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
1 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 9.98 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 10.51 LIMIT LIMIT LIMIT LIMIT LIMIT

Alfred D Kingsley Ownership Network

Ownership Network List of Alfred D Kingsley

No Data

Ownership Network Relation of Alfred D Kingsley

Insider Network Chart

Alfred D Kingsley Owned Company Details

What does Lineage Cell Therapeutics Inc do?

Who are the key executives at Lineage Cell Therapeutics Inc?

Alfred D Kingsley is the other: 13D Group-10% Owner of Lineage Cell Therapeutics Inc. Other key executives at Lineage Cell Therapeutics Inc include Chief Financial Officer Jill Ann Howe , director & President and CEO Brian M Culley , and 10 percent owner Broadwood Partners Lp .

Lineage Cell Therapeutics Inc (LCTX) Insider Trades Summary

Over the past 18 months, Alfred D Kingsley made no insider transaction in Lineage Cell Therapeutics Inc (LCTX). Other recent insider transactions involving Lineage Cell Therapeutics Inc (LCTX) include a net purchase of 6,730,770 shares made by Broadwood Partners Lp , a net purchase of 96,155 shares made by Don M Bailey , and a net purchase of 10,500 shares made by Jill Ann Howe .

In summary, during the past 3 months, insiders sold 0 shares of Lineage Cell Therapeutics Inc (LCTX) in total and bought 10,500 shares, with a net purchase of 10,500 shares. During the past 18 months, 0 shares of Lineage Cell Therapeutics Inc (LCTX) were sold and 6,857,425 shares were bought by its insiders, resulting in a net purchase of 6,857,425 shares.

Lineage Cell Therapeutics Inc (LCTX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Lineage Cell Therapeutics Inc Insider Transactions

No Available Data

Alfred D Kingsley Mailing Address

Above is the net worth, insider trading, and ownership report for Alfred D Kingsley. You might contact Alfred D Kingsley via mailing address: 150 E 57th Street, New York Ny 10022.